Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Current Assets (2020 - 2026)

Alvotech's (ALVO) quarterly Current Assets came in at $545.0 million in Q2 2026, up 6.97% on a YoY basis from $509.5 million in Q2 2025, and up 19.52% quarter-over-quarter from $456.0 million in Q1 2026.

Analysis

Alvotech (ALVO) Current Assets (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Current Assets for 7 consecutive years, with $545.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Assets rose 6.97% year-over-year to $545.0 million; the trailing twelve-month figure through Jun 2026 stood at $545.0 million (up 6.97% YoY), and the FY2025 full-year result was $574.0 million, up 26.15% from the prior year.
  • Current Assets advanced to $545.0 million in Q2 2026 per ALVO's latest filing, from $456.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $574.0 million in Q4 2025 and bottomed at $194.8 million in Q4 2023.
  • Historically, Current Assets has averaged $381.4 million across 5 years, with a median of $443.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Current Assets retreated 15.56% in 2023, then surged 133.53% in 2024.
  • Over 5 years, Current Assets stood at $230.7 million in 2022, then declined by 15.56% to $194.8 million in 2023, then soared by 133.53% to $455.0 million in 2024, then grew by 26.15% to $574.0 million in 2025, then fell by 5.06% to $545.0 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $545.0 million, $456.0 million, and $574.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 13.76 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 10.06 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 3.16 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 1.95 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 6.52 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 825.43 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 544.97 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 630.95 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 72.50 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 544.97 Mn
Mar 31, 2026 455.98 Mn
Dec 31, 2025 574.02 Mn
Sep 30, 2025 455.02 Mn
Jun 30, 2025 509.46 Mn
Mar 31, 2025 458.87 Mn
Dec 31, 2024 455.02 Mn
Sep 30, 2024 432.61 Mn
Jun 30, 2024 285.19 Mn
Mar 31, 2024 292.30 Mn
Dec 31, 2023 194.84 Mn
Jun 30, 2023 211.91 Mn
Dec 31, 2022 230.74 Mn
Jun 30, 2022 238.66 Mn
Dec 31, 2021 119.82 Mn
Dec 31, 2020 86.16 Mn